Although the cerebral ischemia caused by ET-1 injections does not always replicate clinical cases of stroke, the model is still suitable for this study, where the objective is to cause a reduction in CBF leading to infarction, then determine a CBF threshold for distinguishing salvaged tissue from tissue which progressed to infarction. This evidence concerns the gene EDN1 and stroke disorder.